Loading…

Myosteatosis and not low muscle mass is associated with lower survival in kidney transplant recipients

Background Myosteatosis, that is muscle fat infiltration, is an important marker of muscle quality, affecting quality of life and survival in patients with chronic kidney disease (CKD). However, the connection between myosteatosis, skeletal muscle index (SMI) and survival in kidney transplant (KTx)...

Full description

Saved in:
Bibliographic Details
Published in:JCSM communications 2024-07, Vol.7 (2), p.91-98
Main Authors: Huitfeldt Sola, Kristoffer N.D., Genberg, Helena M., Avesani, Carla M., Brismar, Torkel B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1016-e98b3c49e4fda1256118593bd5d7f3e187d6f771c193f6fc76420d06c90679a83
container_end_page 98
container_issue 2
container_start_page 91
container_title JCSM communications
container_volume 7
creator Huitfeldt Sola, Kristoffer N.D.
Genberg, Helena M.
Avesani, Carla M.
Brismar, Torkel B.
description Background Myosteatosis, that is muscle fat infiltration, is an important marker of muscle quality, affecting quality of life and survival in patients with chronic kidney disease (CKD). However, the connection between myosteatosis, skeletal muscle index (SMI) and survival in kidney transplant (KTx) recipients remains unclear. Methods This retrospective observational study included a cohort of consecutive adult kidney recipients transplanted between 2010 and 2017 in Stockholm. Preoperative abdominal computed tomography (CT) images obtained after diagnosis of CKD 5 and within 36 months of transplantation were collected. Using established criteria, we measured muscle area at the third lumbar vertebra (L3 level) and identified low attenuation muscle, indicating myosteatosis. Each area was divided by height squared providing the SMI, and fatty muscle index (FMI). Given that there is no commonly accepted definition of sarcopenia, two cut‐offs for SMI were used to define low muscle mass, Cut‐off 1 (≤32.8 for women and ≤44.7 for men) and Cut‐off 2 (≤38.5 for women and ≤52.4 for men). Average radiodensity of skeletal muscle and Charlson comorbidity index were calculated for each patient. The influence on survival from SMI, FMI, SMI/FMI ratio, and radiodensity was analysed. Results Out of 582 KTx recipients, 266 (46%) had a pre‐transplant abdominal CT available. Applying SMI Cut‐off 1, 30 recipients (11%) had sarcopenia compared with 106 (40%) with Cut‐off 2. Neither SMI nor FMI was associated with survival. Yet there was an association between SMI/FMI ratio and survival, patients with the lowest quintile SMI/FMI ratio having a significantly lower survival when compared with the highest quintile, both in the crude model and when adjusted for age, gender, and comorbidity. Additionally, FMI, radiodensity, and SMI/FMI, but not SMI, were significantly associated with Charlson comorbidity index (P 
doi_str_mv 10.1002/rco2.96
format article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_rco2_96</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RCO296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1016-e98b3c49e4fda1256118593bd5d7f3e187d6f771c193f6fc76420d06c90679a83</originalsourceid><addsrcrecordid>eNp10EtLAzEUBeAgCpZa_AvZuZCpeUyTyVKKL6gURNdDmgdGp0nJTTvMv7dDXbhxdS6cj7s4CF1TMqeEsLtsEpsrcYYmTClRUa7q8z_3JZoBfBFCOGdENs0E-dchQXG6JAiAdbQ4poK71OPtHkzn8FYD4LECSCbo4izuQ_kcicsY9vkQDrrDIeLvYKMbcMk6wq7TseDsTNgFFwtcoQuvO3Cz35yij8eH9-VztVo_vSzvV5WhhIrKqWbDTa1c7a2mbCEobRaKb-zCSs8dbaQVXkpqqOJeeCNFzYglwigipNINn6Kb01-TE0B2vt3lsNV5aClpx4XacaFWiaO8Pck-dG74j7VvyzU76h_sV2iX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Myosteatosis and not low muscle mass is associated with lower survival in kidney transplant recipients</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Huitfeldt Sola, Kristoffer N.D. ; Genberg, Helena M. ; Avesani, Carla M. ; Brismar, Torkel B.</creator><creatorcontrib>Huitfeldt Sola, Kristoffer N.D. ; Genberg, Helena M. ; Avesani, Carla M. ; Brismar, Torkel B.</creatorcontrib><description>Background Myosteatosis, that is muscle fat infiltration, is an important marker of muscle quality, affecting quality of life and survival in patients with chronic kidney disease (CKD). However, the connection between myosteatosis, skeletal muscle index (SMI) and survival in kidney transplant (KTx) recipients remains unclear. Methods This retrospective observational study included a cohort of consecutive adult kidney recipients transplanted between 2010 and 2017 in Stockholm. Preoperative abdominal computed tomography (CT) images obtained after diagnosis of CKD 5 and within 36 months of transplantation were collected. Using established criteria, we measured muscle area at the third lumbar vertebra (L3 level) and identified low attenuation muscle, indicating myosteatosis. Each area was divided by height squared providing the SMI, and fatty muscle index (FMI). Given that there is no commonly accepted definition of sarcopenia, two cut‐offs for SMI were used to define low muscle mass, Cut‐off 1 (≤32.8 for women and ≤44.7 for men) and Cut‐off 2 (≤38.5 for women and ≤52.4 for men). Average radiodensity of skeletal muscle and Charlson comorbidity index were calculated for each patient. The influence on survival from SMI, FMI, SMI/FMI ratio, and radiodensity was analysed. Results Out of 582 KTx recipients, 266 (46%) had a pre‐transplant abdominal CT available. Applying SMI Cut‐off 1, 30 recipients (11%) had sarcopenia compared with 106 (40%) with Cut‐off 2. Neither SMI nor FMI was associated with survival. Yet there was an association between SMI/FMI ratio and survival, patients with the lowest quintile SMI/FMI ratio having a significantly lower survival when compared with the highest quintile, both in the crude model and when adjusted for age, gender, and comorbidity. Additionally, FMI, radiodensity, and SMI/FMI, but not SMI, were significantly associated with Charlson comorbidity index (P &lt; 0.01). Conclusions The SMI/FMI ratio may be associated with both pre‐transplant comorbidity and post‐transplant survival even though the significance of SMI is unclear. This suggests that SMI/FMI ratio is a better indicator of muscular impairment than skeletal muscle quantity alone. The finding may reflect the complex interplay between muscle mass, muscular fat infiltration and metabolic health, all important determinants of wellness and longevity. In summary, our study underscores the potential of the SMI/FMI ratio as a predictor of outcome after KTx, a finding possibly transferable to other patient populations.</description><identifier>ISSN: 2996-1394</identifier><identifier>EISSN: 2996-1394</identifier><identifier>DOI: 10.1002/rco2.96</identifier><language>eng</language><subject>Computed tomography ; Kidney transplantation ; Myosteatosis ; Sarcopenia ; Survival analysis</subject><ispartof>JCSM communications, 2024-07, Vol.7 (2), p.91-98</ispartof><rights>2024 The Author(s). JCSM Communications published by Wiley Periodicals LLC.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1016-e98b3c49e4fda1256118593bd5d7f3e187d6f771c193f6fc76420d06c90679a83</cites><orcidid>0000-0002-9278-3326</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Frco2.96$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Frco2.96$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,11561,27923,27924,46051,46475</link.rule.ids></links><search><creatorcontrib>Huitfeldt Sola, Kristoffer N.D.</creatorcontrib><creatorcontrib>Genberg, Helena M.</creatorcontrib><creatorcontrib>Avesani, Carla M.</creatorcontrib><creatorcontrib>Brismar, Torkel B.</creatorcontrib><title>Myosteatosis and not low muscle mass is associated with lower survival in kidney transplant recipients</title><title>JCSM communications</title><description>Background Myosteatosis, that is muscle fat infiltration, is an important marker of muscle quality, affecting quality of life and survival in patients with chronic kidney disease (CKD). However, the connection between myosteatosis, skeletal muscle index (SMI) and survival in kidney transplant (KTx) recipients remains unclear. Methods This retrospective observational study included a cohort of consecutive adult kidney recipients transplanted between 2010 and 2017 in Stockholm. Preoperative abdominal computed tomography (CT) images obtained after diagnosis of CKD 5 and within 36 months of transplantation were collected. Using established criteria, we measured muscle area at the third lumbar vertebra (L3 level) and identified low attenuation muscle, indicating myosteatosis. Each area was divided by height squared providing the SMI, and fatty muscle index (FMI). Given that there is no commonly accepted definition of sarcopenia, two cut‐offs for SMI were used to define low muscle mass, Cut‐off 1 (≤32.8 for women and ≤44.7 for men) and Cut‐off 2 (≤38.5 for women and ≤52.4 for men). Average radiodensity of skeletal muscle and Charlson comorbidity index were calculated for each patient. The influence on survival from SMI, FMI, SMI/FMI ratio, and radiodensity was analysed. Results Out of 582 KTx recipients, 266 (46%) had a pre‐transplant abdominal CT available. Applying SMI Cut‐off 1, 30 recipients (11%) had sarcopenia compared with 106 (40%) with Cut‐off 2. Neither SMI nor FMI was associated with survival. Yet there was an association between SMI/FMI ratio and survival, patients with the lowest quintile SMI/FMI ratio having a significantly lower survival when compared with the highest quintile, both in the crude model and when adjusted for age, gender, and comorbidity. Additionally, FMI, radiodensity, and SMI/FMI, but not SMI, were significantly associated with Charlson comorbidity index (P &lt; 0.01). Conclusions The SMI/FMI ratio may be associated with both pre‐transplant comorbidity and post‐transplant survival even though the significance of SMI is unclear. This suggests that SMI/FMI ratio is a better indicator of muscular impairment than skeletal muscle quantity alone. The finding may reflect the complex interplay between muscle mass, muscular fat infiltration and metabolic health, all important determinants of wellness and longevity. In summary, our study underscores the potential of the SMI/FMI ratio as a predictor of outcome after KTx, a finding possibly transferable to other patient populations.</description><subject>Computed tomography</subject><subject>Kidney transplantation</subject><subject>Myosteatosis</subject><subject>Sarcopenia</subject><subject>Survival analysis</subject><issn>2996-1394</issn><issn>2996-1394</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp10EtLAzEUBeAgCpZa_AvZuZCpeUyTyVKKL6gURNdDmgdGp0nJTTvMv7dDXbhxdS6cj7s4CF1TMqeEsLtsEpsrcYYmTClRUa7q8z_3JZoBfBFCOGdENs0E-dchQXG6JAiAdbQ4poK71OPtHkzn8FYD4LECSCbo4izuQ_kcicsY9vkQDrrDIeLvYKMbcMk6wq7TseDsTNgFFwtcoQuvO3Cz35yij8eH9-VztVo_vSzvV5WhhIrKqWbDTa1c7a2mbCEobRaKb-zCSs8dbaQVXkpqqOJeeCNFzYglwigipNINn6Kb01-TE0B2vt3lsNV5aClpx4XacaFWiaO8Pck-dG74j7VvyzU76h_sV2iX</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Huitfeldt Sola, Kristoffer N.D.</creator><creator>Genberg, Helena M.</creator><creator>Avesani, Carla M.</creator><creator>Brismar, Torkel B.</creator><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-9278-3326</orcidid></search><sort><creationdate>202407</creationdate><title>Myosteatosis and not low muscle mass is associated with lower survival in kidney transplant recipients</title><author>Huitfeldt Sola, Kristoffer N.D. ; Genberg, Helena M. ; Avesani, Carla M. ; Brismar, Torkel B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1016-e98b3c49e4fda1256118593bd5d7f3e187d6f771c193f6fc76420d06c90679a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Computed tomography</topic><topic>Kidney transplantation</topic><topic>Myosteatosis</topic><topic>Sarcopenia</topic><topic>Survival analysis</topic><toplevel>online_resources</toplevel><creatorcontrib>Huitfeldt Sola, Kristoffer N.D.</creatorcontrib><creatorcontrib>Genberg, Helena M.</creatorcontrib><creatorcontrib>Avesani, Carla M.</creatorcontrib><creatorcontrib>Brismar, Torkel B.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Free Content</collection><collection>CrossRef</collection><jtitle>JCSM communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huitfeldt Sola, Kristoffer N.D.</au><au>Genberg, Helena M.</au><au>Avesani, Carla M.</au><au>Brismar, Torkel B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myosteatosis and not low muscle mass is associated with lower survival in kidney transplant recipients</atitle><jtitle>JCSM communications</jtitle><date>2024-07</date><risdate>2024</risdate><volume>7</volume><issue>2</issue><spage>91</spage><epage>98</epage><pages>91-98</pages><issn>2996-1394</issn><eissn>2996-1394</eissn><abstract>Background Myosteatosis, that is muscle fat infiltration, is an important marker of muscle quality, affecting quality of life and survival in patients with chronic kidney disease (CKD). However, the connection between myosteatosis, skeletal muscle index (SMI) and survival in kidney transplant (KTx) recipients remains unclear. Methods This retrospective observational study included a cohort of consecutive adult kidney recipients transplanted between 2010 and 2017 in Stockholm. Preoperative abdominal computed tomography (CT) images obtained after diagnosis of CKD 5 and within 36 months of transplantation were collected. Using established criteria, we measured muscle area at the third lumbar vertebra (L3 level) and identified low attenuation muscle, indicating myosteatosis. Each area was divided by height squared providing the SMI, and fatty muscle index (FMI). Given that there is no commonly accepted definition of sarcopenia, two cut‐offs for SMI were used to define low muscle mass, Cut‐off 1 (≤32.8 for women and ≤44.7 for men) and Cut‐off 2 (≤38.5 for women and ≤52.4 for men). Average radiodensity of skeletal muscle and Charlson comorbidity index were calculated for each patient. The influence on survival from SMI, FMI, SMI/FMI ratio, and radiodensity was analysed. Results Out of 582 KTx recipients, 266 (46%) had a pre‐transplant abdominal CT available. Applying SMI Cut‐off 1, 30 recipients (11%) had sarcopenia compared with 106 (40%) with Cut‐off 2. Neither SMI nor FMI was associated with survival. Yet there was an association between SMI/FMI ratio and survival, patients with the lowest quintile SMI/FMI ratio having a significantly lower survival when compared with the highest quintile, both in the crude model and when adjusted for age, gender, and comorbidity. Additionally, FMI, radiodensity, and SMI/FMI, but not SMI, were significantly associated with Charlson comorbidity index (P &lt; 0.01). Conclusions The SMI/FMI ratio may be associated with both pre‐transplant comorbidity and post‐transplant survival even though the significance of SMI is unclear. This suggests that SMI/FMI ratio is a better indicator of muscular impairment than skeletal muscle quantity alone. The finding may reflect the complex interplay between muscle mass, muscular fat infiltration and metabolic health, all important determinants of wellness and longevity. In summary, our study underscores the potential of the SMI/FMI ratio as a predictor of outcome after KTx, a finding possibly transferable to other patient populations.</abstract><doi>10.1002/rco2.96</doi><tpages>98</tpages><orcidid>https://orcid.org/0000-0002-9278-3326</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2996-1394
ispartof JCSM communications, 2024-07, Vol.7 (2), p.91-98
issn 2996-1394
2996-1394
language eng
recordid cdi_crossref_primary_10_1002_rco2_96
source Open Access: Wiley-Blackwell Open Access Journals
subjects Computed tomography
Kidney transplantation
Myosteatosis
Sarcopenia
Survival analysis
title Myosteatosis and not low muscle mass is associated with lower survival in kidney transplant recipients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A03%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myosteatosis%20and%20not%20low%20muscle%20mass%20is%20associated%20with%20lower%20survival%20in%20kidney%20transplant%20recipients&rft.jtitle=JCSM%20communications&rft.au=Huitfeldt%20Sola,%20Kristoffer%20N.D.&rft.date=2024-07&rft.volume=7&rft.issue=2&rft.spage=91&rft.epage=98&rft.pages=91-98&rft.issn=2996-1394&rft.eissn=2996-1394&rft_id=info:doi/10.1002/rco2.96&rft_dat=%3Cwiley_cross%3ERCO296%3C/wiley_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1016-e98b3c49e4fda1256118593bd5d7f3e187d6f771c193f6fc76420d06c90679a83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true